Biopharma: Instead of M&A, Think P&A [View article]
I see very few M@A going forward.
Yes indeed, big Pharma has cash but - they do not have brains - the present political environment in the USA is so uncertain, it is very difficult to plan ahead.
Consequently, any acquired company must have very specific & attractive features to be a target for the next 3-8 months.
Biopharma: Instead of M&A, Think P&A [View article]
Yes indeed, big Pharma has cash but
- they do not have brains
- the present political environment in the USA is so uncertain, it is very difficult to plan ahead.
Consequently, any acquired company must have very specific & attractive features to be a target for the next 3-8 months.